These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11741388)

  • 1. The ons and offs of inducible transgenic technology: a review.
    Yamamoto A; Hen R; Dauer WT
    Neurobiol Dis; 2001 Dec; 8(6):923-32. PubMed ID: 11741388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A versatile tool for conditional gene expression and knockdown.
    Szulc J; Wiznerowicz M; Sauvain MO; Trono D; Aebischer P
    Nat Methods; 2006 Feb; 3(2):109-16. PubMed ID: 16432520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal transgenesis: an overview.
    Gama Sosa MA; De Gasperi R; Elder GA
    Brain Struct Funct; 2010 Mar; 214(2-3):91-109. PubMed ID: 19937345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model.
    Gabril MY; Onita T; Ji PG; Sakai H; Chan FL; Koropatnick J; Chin JL; Moussa M; Xuan JW
    Gene Ther; 2002 Dec; 9(23):1589-99. PubMed ID: 12424611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.
    Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F
    Mol Ther; 2004 Oct; 10(4):660-70. PubMed ID: 15451450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the use of the T-REx tetracycline-inducible gene expression system in vivo.
    Dobrovolsky VN; Heflich RH
    Biotechnol Bioeng; 2007 Oct; 98(3):719-23. PubMed ID: 17421042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nature, nurture and neurology: gene-environment interactions in neurodegenerative disease. FEBS Anniversary Prize Lecture delivered on 27 June 2004 at the 29th FEBS Congress in Warsaw.
    Spires TL; Hannan AJ
    FEBS J; 2005 May; 272(10):2347-61. PubMed ID: 15885086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatiotemporal gene expression targeting with the TARGET and gene-switch systems in Drosophila.
    McGuire SE; Mao Z; Davis RL
    Sci STKE; 2004 Feb; 2004(220):pl6. PubMed ID: 14970377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible and selective transgene expression in murine vascular endothelium.
    Teng PI; Dichiara MR; Kömüves LG; Abe K; Quertermous T; Topper JN
    Physiol Genomics; 2002 Oct; 11(2):99-107. PubMed ID: 12388791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell labeling and gene misexpression by electroporation.
    Van Raay TJ; Stark MR
    Methods Mol Biol; 2002; 198():223-32. PubMed ID: 11951624
    [No Abstract]   [Full Text] [Related]  

  • 11. BAC to immunology--bacterial artificial chromosome-mediated transgenesis for targeting of immune cells.
    Sparwasser T; Eberl G
    Immunology; 2007 Jul; 121(3):308-13. PubMed ID: 17437533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pronuclear injection for the production of transgenic mice.
    Ittner LM; Götz J
    Nat Protoc; 2007; 2(5):1206-15. PubMed ID: 17546016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific transgenic and knockout mice.
    Porret A; Mérillat AM; Guichard S; Beermann F; Hummler E
    Methods Mol Biol; 2006; 337():185-205. PubMed ID: 16929948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell type-specific conditional regulation of the c-myc proto-oncogene by combining Cre/loxP recombination and tamoxifen-mediated activation.
    Jäger R; Maurer J; Jacob A; Schorle H
    Genesis; 2004 Mar; 38(3):145-50. PubMed ID: 15048812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo.
    Shevtsova Z; Malik JM; Michel U; Bähr M; Kügler S
    Exp Physiol; 2005 Jan; 90(1):53-9. PubMed ID: 15542619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional gene targeting in the mouse nervous system: Insights into brain function and diseases.
    Gavériaux-Ruff C; Kieffer BL
    Pharmacol Ther; 2007 Mar; 113(3):619-34. PubMed ID: 17289150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer therapy for neurodegenerative disorders.
    Feigin A; Eidelberg D
    Mov Disord; 2007 Jul; 22(9):1223-8; quiz 1369. PubMed ID: 17393533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible neuronal expression of transgenic TGF-beta1 in vivo: dissection of short-term and long-term effects.
    Ueberham U; Ueberham E; Brückner MK; Seeger G; Gärtner U; Gruschka H; Gebhardt R; Arendt T
    Eur J Neurosci; 2005 Jul; 22(1):50-64. PubMed ID: 16029195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo transgene expression using an adenoviral tetracycline-regulated system with neuron-specific enolase promoter.
    Bhattacharjee AK; Ueyama T; Kondoh T; Hayashi S; Abouelfetouh A; Sakai N; Saito N; Kohmura E
    Biochem Biophys Res Commun; 2004 May; 317(4):1144-8. PubMed ID: 15094388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.